Novartis Nabs Partial Ban Against MSN's Heart Drug Generic
Novartis AG succeeded Monday in blocking a competitor from potentially selling a similar-looking generic drug for treating heart failure, with a New Jersey federal judge remarking that MSN Laboratories Pvt. Ltd. "could...To view the full article, register now.
Already a subscriber? Click here to view full article